Alejandro Balsa Selected Research

Alejandro Balsa Research Topics

Disease

97	Rheumatoid Arthritis 02/2024 - 04/2003
11	Inflammation (Inflammations) 01/2021 - 07/2004
10	Necrosis 02/2024 - 12/2012
9	Arthritis (Polyarthritis) 03/2022 - 05/2007
7	Rheumatic Diseases (Rheumatism) 01/2024 - 09/2011
7	Axial Spondyloarthritis 01/2023 - 01/2016
6	Atherosclerosis 01/2016 - 01/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2011
4	Infections 08/2023 - 02/2009
4	Ankylosing Spondylitis 01/2022 - 07/2013
4	Psoriatic Arthritis 01/2020 - 08/2017
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2005
3	Obesity 01/2023 - 09/2022
2	Overweight 01/2023 - 01/2019
2	Neoplasms (Cancer) 01/2023 - 08/2012
2	Disease Progression 12/2020 - 01/2015
2	Multiple Sclerosis 01/2018 - 09/2007
2	Dyslipidemias (Dyslipidemia) 01/2017 - 08/2012
2	Autoimmune Diseases (Autoimmune Disease) 09/2007 - 01/2007
2	Genetic Predisposition to Disease (Genetic Predisposition) 05/2007 - 12/2006
1	Body Weight (Weight, Body) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2021
1	Posterior Uveitis 09/2019
1	Uveitis 09/2019
1	Anterior Uveitis 09/2019
1	Osteoporosis 03/2019
1	Human Influenza (Influenza) 03/2019
1	Gout 09/2017
1	Non-Radiographic Axial Spondyloarthritis 08/2017
1	Ulcerative Colitis 08/2017

Drug/Important Bio-Agent (IBA)

19	Tumor Necrosis Factor InhibitorsIBA 02/2024 - 12/2007
16	AntibodiesIBA 01/2024 - 05/2007
14	Infliximab (Remicade)FDA Link 01/2024 - 04/2004
13	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2012
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2007
12	Antirheumatic Agents (DMARD)IBA 01/2023 - 04/2003
9	Anti-Citrullinated Protein AntibodiesIBA 11/2020 - 05/2010
8	Rheumatoid FactorIBA 02/2024 - 09/2009
8	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 07/2004
7	AutoantibodiesIBA 01/2023 - 04/2015
7	CytokinesIBA 01/2023 - 07/2004
7	Adalimumab (Humira)FDA Link 01/2023 - 03/2015
6	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021 - 01/2010
5	Rituximab (Mabthera)FDA Link 08/2023 - 01/2011
5	tocilizumab (atlizumab)FDA Link 01/2023 - 09/2015
5	Interleukin-15 (Interleukin 15)IBA 12/2009 - 07/2004
4	Abatacept (Orencia)FDA Link 02/2024 - 01/2013
4	baricitinibIBA 01/2023 - 01/2019
4	golimumab FDA Link 01/2023 - 01/2018
4	Etanercept (Enbrel)FDA Link 01/2023 - 01/2014
4	cyclic citrullinated peptideIBA 01/2021 - 09/2009
3	Certolizumab Pegol FDA Link 02/2024 - 01/2020
3	Janus Kinase InhibitorsIBA 12/2023 - 01/2020
3	GLPG0634IBA 12/2023 - 01/2020
3	Biosimilar PharmaceuticalsIBA 01/2023 - 08/2017
3	C-Reactive ProteinIBA 01/2022 - 02/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 03/2014
3	Peptides (Polypeptides)IBA 03/2015 - 05/2007
3	EpitopesIBA 01/2015 - 09/2009
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 07/2004
2	Immunomodulating AgentsIBA 08/2023 - 09/2019
2	sarilumabIBA 01/2023 - 01/2020
2	Leflunomide (Arava)FDA LinkGeneric 01/2023 - 01/2020
2	tofacitinibIBA 01/2023 - 01/2020
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2023 - 01/2020
2	AdipokinesIBA 01/2023 - 09/2022
2	upadacitinibIBA 01/2023 - 01/2020
2	Immunoglobulin G (IgG)IBA 03/2022 - 03/2015
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2019 - 02/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 10/2016
2	acetyl 4-aminosalicylic acidIBA 08/2016 - 03/2015
2	OsteopontinIBA 03/2015 - 03/2005
2	Genetic Markers (Genetic Marker)IBA 01/2015 - 01/2014
2	Interferon Regulatory FactorsIBA 07/2014 - 01/2011
2	Monoclonal AntibodiesIBA 12/2012 - 09/2004
2	Messenger RNA (mRNA)IBA 10/2012 - 12/2006
2	NF-kappa B (NF-kB)IBA 01/2009 - 10/2007
1	ProteomeIBA 01/2024
1	Prostaglandins AIBA 01/2023
1	AdiponectinIBA 01/2023
1	N-phthaloylglutamic acidIBA 01/2023
1	Interleukin-6 InhibitorsIBA 01/2023
1	LeptinIBA 01/2023
1	B-Cell Activating FactorIBA 09/2022
1	Immunoglobulin A (IgA)IBA 03/2022
1	Immunoglobulin M (IgM)IBA 03/2022
1	HLA-B Antigens (HLA-B)IBA 01/2021
1	OrnithineIBA 11/2020
1	Janus KinasesIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 09/2019
1	SteroidsIBA 09/2019
1	Vitamin D FDA LinkGeneric 03/2019
1	Anti-Idiotypic AntibodiesIBA 01/2019
1	Uric Acid (Urate)IBA 09/2017

Therapy/Procedure

18	Therapeutics 01/2024 - 04/2004
13	Biological Therapy 12/2023 - 09/2011
1	Polypharmacy 11/2022
1	Drug Tapering 12/2019